InnoPharmax Inc. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 55.666 million compared to TWD 21.863 million a year ago. Operating loss was TWD 18.271 million compared to TWD 47.333 million a year ago. Net loss was TWD 23.163 million compared to TWD 47.814 million a year ago. Basic loss per share was TWD 0.3 compared to TWD 0.68 a year ago.